PURPOSE: Population-based studies have established a link between race and prostate cancer (PC) risk, but whether race predicts PC after adjusting for clinical characteristics is unclear. We investigated the association between race and risk of low- and high-grade PC in men undergoing initial prostate biopsy in an equal access medical center. METHODS: We conducted a retrospective record review of 887 men (48.6 % black, 51.4 % white) from the Durham Veterans Affairs Medical Center who underwent initial prostate biopsy between 2001 and 2009. Multivariable logistic regression analysis of race and biopsy outcome was conducted adjusting for age, body mass index, number of cores taken, prostate-specific antigen (PSA), and digital rectal examination findings. Multinomial logistic regression was used to test the association between black race and PC grade (Gleason <7 vs. ≥7). RESULTS: Black men were younger at biopsy (61 vs. 65 years, p < 0.001) and had a higher pre-biopsy PSA (6.6 vs. 5.8 ng/ml, p = 0.001). A total of 499 men had PC on biopsy (245 low grade; 254 high grade). In multivariable analyses, black race was significantly predictive of PC overall [odds ratio 1.50, p = 0.006] and high-grade PC [relative risk ratio (RRR) 1.84, p = 0.001], but was not significantly associated with low-grade PC (RRR 1.29, p = 0.139). CONCLUSION: In an equal access healthcare facility, black race was associated with greater risk of PC detection on initial biopsy and of high-grade PC after adjusting for clinical characteristics. Additional investigation of mechanisms linking black race and PC risk and PC aggressiveness is needed.
PURPOSE: Population-based studies have established a link between race and prostate cancer (PC) risk, but whether race predicts PC after adjusting for clinical characteristics is unclear. We investigated the association between race and risk of low- and high-grade PC in men undergoing initial prostate biopsy in an equal access medical center. METHODS: We conducted a retrospective record review of 887 men (48.6 % black, 51.4 % white) from the Durham Veterans Affairs Medical Center who underwent initial prostate biopsy between 2001 and 2009. Multivariable logistic regression analysis of race and biopsy outcome was conducted adjusting for age, body mass index, number of cores taken, prostate-specific antigen (PSA), and digital rectal examination findings. Multinomial logistic regression was used to test the association between black race and PC grade (Gleason <7 vs. ≥7). RESULTS: Black men were younger at biopsy (61 vs. 65 years, p < 0.001) and had a higher pre-biopsy PSA (6.6 vs. 5.8 ng/ml, p = 0.001). A total of 499 men had PC on biopsy (245 low grade; 254 high grade). In multivariable analyses, black race was significantly predictive of PC overall [odds ratio 1.50, p = 0.006] and high-grade PC [relative risk ratio (RRR) 1.84, p = 0.001], but was not significantly associated with low-grade PC (RRR 1.29, p = 0.139). CONCLUSION: In an equal access healthcare facility, black race was associated with greater risk of PC detection on initial biopsy and of high-grade PC after adjusting for clinical characteristics. Additional investigation of mechanisms linking black race and PC risk and PC aggressiveness is needed.
Authors: Leah L Zullig; George L Jackson; Raye Anne Dorn; Dawn T Provenzale; Rebecca McNeil; Catherine M Thomas; Michael J Kelley Journal: Mil Med Date: 2012-06 Impact factor: 1.437
Authors: Brent V Yanke; Brett S Carver; Fernando J Bianco; Walter J Simoneaux; Dennis D Venable; Isaac J Powell; James A Eastham Journal: BJU Int Date: 2006-10 Impact factor: 5.588
Authors: Stephen J Freedland; Elizabeth B Humphreys; Leslie A Mangold; Mario Eisenberger; Frederick J Dorey; Patrick C Walsh; Alan W Partin Journal: JAMA Date: 2005-07-27 Impact factor: 56.272
Authors: M Tsivian; L L Bañez; C J Keto; M R Abern; P Qi; L Gerber; J W Moul; T J Polascik Journal: Prostate Cancer Prostatic Dis Date: 2012-10-02 Impact factor: 5.554
Authors: Xianglin L Du; Shenying Fang; Ann L Coker; Maureen Sanderson; Corrine Aragaki; Janice N Cormier; Yan Xing; Beverly J Gor; Wenyaw Chan Journal: Cancer Date: 2006-03-15 Impact factor: 6.860
Authors: Gilles Thomas; Kevin B Jacobs; Meredith Yeager; Peter Kraft; Sholom Wacholder; Nick Orr; Kai Yu; Nilanjan Chatterjee; Robert Welch; Amy Hutchinson; Andrew Crenshaw; Geraldine Cancel-Tassin; Brian J Staats; Zhaoming Wang; Jesus Gonzalez-Bosquet; Jun Fang; Xiang Deng; Sonja I Berndt; Eugenia E Calle; Heather Spencer Feigelson; Michael J Thun; Carmen Rodriguez; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Fredrick R Schumacher; Edward Giovannucci; Walter C Willett; Olivier Cussenot; Antoine Valeri; Gerald L Andriole; E David Crawford; Margaret Tucker; Daniela S Gerhard; Joseph F Fraumeni; Robert Hoover; Richard B Hayes; David J Hunter; Stephen J Chanock Journal: Nat Genet Date: 2008-02-10 Impact factor: 38.330
Authors: Brett S Carver; Caleb B Bozeman; Walter J Simoneaux; Dennis D Venable; Michael W Kattan; James A Eastham Journal: J Urol Date: 2004-11 Impact factor: 7.450
Authors: Michael S Leapman; Stephen J Freedland; William J Aronson; Christopher J Kane; Martha K Terris; Kelly Walker; Christopher L Amling; Peter R Carroll; Matthew R Cooperberg Journal: J Urol Date: 2016-06-25 Impact factor: 7.450
Authors: Oluwarotimi S Nettey; Austin J Walker; Mary Kate Keeter; Ashima Singal; Aishwarya Nugooru; Iman K Martin; Maria Ruden; Pooja Gogana; Michael A Dixon; Tijani Osuma; Courtney M P Hollowell; Roohollah Sharifi; Marin Sekosan; Ximing Yang; William J Catalona; Andre Kajdacsy-Balla; Virgilia Macias; Rick A Kittles; Adam B Murphy Journal: Urol Oncol Date: 2018-09-17 Impact factor: 3.498
Authors: William A Sterling; Joseph Weiner; David Schreiber; Komal Mehta; Jeffrey P Weiss Journal: Int Urol Nephrol Date: 2016-08-31 Impact factor: 2.370
Authors: Adriana C Vidal; Lauren E Howard; Amanda De Hoedt; Christopher J Kane; Martha K Terris; William J Aronson; Matthew R Cooperberg; Christopher L Amling; Stanislav Lechpammer; Scott C Flanders; Stephen J Freedland Journal: Cancer Date: 2018-11-14 Impact factor: 6.860
Authors: K A Moses; Z Zhao; Y Bi; J Acquaye; A Holmes; W J Blot; J H Fowke Journal: Prostate Cancer Prostatic Dis Date: 2017-07-11 Impact factor: 5.554
Authors: Wendy E Barrington; Jeannette M Schenk; Ruth Etzioni; Kathryn B Arnold; Marian L Neuhouser; Ian M Thompson; M Scott Lucia; Alan R Kristal Journal: JAMA Oncol Date: 2015-06 Impact factor: 31.777